Stock listing
OTC:NVSEF Novartis AG Stock
US listing (OTC) of Novartis AG · home listing SIX Swiss:NOVN
Follow Novartis AG into a list and get an email when it puts out news.
Share price · OTC:NVSEF
$159.26 USD -2.86 (-1.8%)
Close on Nov 16, 2026
- Day range
- $159.26 – $165.52 USDNov 16, 2026
- Volume
- 403 sharesNov 16, 2026
- Market cap
- $302.7B USDAt the close on Nov 16, 2026 · price × 1.90B shares outstanding
- 52-week range
- $123.69 – $171.29 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $4.28M USDMedian day 856 shares · 2 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:NOVN · Home | 134.26 CHF | -1.50 (-1.1%) | 374,101 | 134.98 | 135.28 | 134.14 | 135.76 | Delayed 15+ min · 12:44 PM GMT+1, Nov 17, 2026 |
| NYSE:NVS | $160.20 USD | -0.30 (-0.2%) | 1,630,384 | $162.36 | $163.28 | $159.94 | $160.50 | Close on Nov 16, 2026 |
| OTC:NVSEF | $159.26 USD | -2.855 (-1.8%) | 403 | $165.52 | $165.52 | $159.26 | $162.12 | Close on Nov 16, 2026 |
| Frankfurt:NOTA | €145.00 EUR | +2.00 (+1.4%) | — | €145.00 | €145.00 | €145.00 | €143.00 | Close on Nov 16, 2026 |
| B3:N1VS34 | 93.42 BRL | +2.34 (+2.6%) | 49 | 92.85 | 93.69 | 91.08 | 91.08 | Close on Nov 16, 2026 |
| TSX:NVS | $32.32 CAD | +0.31 (+1.0%) | 421 | $32.55 | $32.55 | $32.32 | $32.01 | Close on Nov 16, 2026 |
| LSE:0K9E | $161.15 USD | +0.85 (+0.5%) | 993 | $160.99 | $163.99 | $160.99 | $160.30 | Close on Nov 16, 2026 |
| Stuttgart:NOT | €145.60 EUR | +0.12 (+0.1%) | — | €145.28 | €148.02 | €145.28 | €145.48 | Close on Nov 16, 2026 |
| Munich:NOT | €145.90 EUR | +0.96 (+0.7%) | — | €145.94 | €145.94 | €145.90 | €144.94 | Close on Nov 16, 2026 |
| Dusseldorf:NOT | €145.52 EUR | +0.04 (0.0%) | — | €145.52 | €145.52 | €145.52 | €145.48 | Close on Nov 16, 2026 |
| Stuttgart:NOTA | €144.00 EUR | -2.00 (-1.4%) | 70 | €146.00 | €147.00 | €143.00 | €146.00 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · OTC:NVSEF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $160.97 | +0.74 | +0.5% | $160.97 | $160.97 | $160.97 | 700 | |
| $160.23 | -0.49 | -0.3% | $159.20 | $160.23 | $159.20 | 500 | |
| $160.72 | +2.05 | +1.3% | $157.93 | $160.72 | $157.93 | 400 | |
| $158.67 | +1.22 | +0.8% | $160.42 | $160.42 | $158.67 | 11,100 | |
| $157.45 | -2.90 | -1.8% | $157.45 | $157.45 | $157.45 | 2,500 | |
| $160.35 | 0.00 | 0.0% | $160.35 | $160.35 | $160.35 | 0 | |
| $160.35 | +0.35 | +0.2% | $160.00 | $160.35 | $160.00 | 1,700 | |
| $160.00 | +9.88 | +6.6% | $152.01 | $160.00 | $152.01 | 400 | |
| $150.12 | 0.00 | 0.0% | $150.12 | $150.12 | $150.12 | 0 | |
| $150.12 | +0.31 | +0.2% | $148.65 | $150.12 | $148.65 | 800 | |
| $149.81 | +3.63 | +2.5% | $157.60 | $157.60 | $149.81 | 140,400 | |
| $146.18 | -0.275 | -0.2% | $146.24 | $146.34 | $146.18 | 2,904 | |
| $146.46 | +2.555 | +1.8% | $153.25 | $153.36 | $146.46 | 863 | |
| $143.90 | -0.42 | -0.3% | $153.90 | $153.90 | $143.90 | 1,212 | |
| $144.32 | +6.52 | +4.7% | $153.92 | $153.92 | $144.32 | 234,755 | |
| $137.80 | -5.38 | -3.8% | $140.73 | $140.73 | $137.80 | 854 | |
| $143.18 | +3.198 | +2.3% | $143.18 | $143.18 | $143.18 | 351 | |
| $139.98 | +4.232 | +3.1% | $146.23 | $146.23 | $139.98 | 581 | |
| $135.75 | +1.53 | +1.1% | $141.95 | $141.95 | $135.75 | 414 | |
| $134.22 | -0.31 | -0.2% | $140.60 | $140.60 | $134.22 | 164,548 | |
| $134.53 | +0.33 | +0.2% | $136.39 | $136.39 | $134.53 | 1,242 | |
| $134.20 | -6.73 | -4.8% | $134.20 | $137.40 | $134.20 | 633 | |
| $140.93 | -4.005 | -2.8% | $140.93 | $140.93 | $140.93 | 303,471 | |
| $144.94 | -1.065 | -0.7% | $139.02 | $144.94 | $139.02 | 100,304 | |
| $146.00 | +5.042 | +3.6% | $142.68 | $146.00 | $139.41 | 5,925 | |
| $140.96 | -1.549 | -1.1% | $140.96 | $140.96 | $140.96 | 312 | |
| $142.51 | +4.127 | +3.0% | $138.10 | $142.51 | $138.10 | 557 | |
| $138.38 | +0.128 | +0.1% | $138.38 | $138.38 | $138.38 | 36,792 | |
| $138.25 | +4.552 | +3.4% | $140.63 | $140.63 | $138.25 | 289 | |
| $133.70 | -8.363 | -5.9% | $137.12 | $146.75 | $133.70 | 2,175 | |
| $142.06 | +7.313 | +5.4% | $140.61 | $142.06 | $132.81 | 970 | |
| $134.75 | -3.015 | -2.2% | $137.25 | $137.41 | $134.75 | 2,908 | |
| $137.77 | -0.185 | -0.1% | $137.77 | $137.77 | $137.77 | 300,459 | |
| $137.95 | -0.55 | -0.4% | $137.38 | $137.95 | $137.38 | 898 | |
| $138.50 | -25.75 | -15.7% | $138.50 | $138.50 | $138.50 | 339 | |
| $164.25 | +7.455 | +4.8% | $164.25 | $164.25 | $164.25 | 3,983 | |
| $156.80 | -5.30 | -3.3% | $156.80 | $156.80 | $156.80 | 236 | |
| $162.10 | +17.09 | +11.8% | $158.07 | $164.62 | $158.07 | 802 | |
| $145.01 | -18.59 | -11.4% | $145.01 | $145.01 | $145.01 | 385 | |
| $163.60 | +5.99 | +3.8% | $160.25 | $163.60 | $160.25 | 533 | |
| $157.61 | -2.39 | -1.5% | $157.61 | $157.61 | $157.61 | 380 | |
| $160.00 | +10.27 | +6.9% | $160.00 | $160.00 | $160.00 | 2,294 | |
| $149.73 | +3.797 | +2.6% | $149.73 | $149.73 | $149.73 | 169 | |
| $145.93 | -11.96 | -7.6% | $149.28 | $149.28 | $145.93 | 857 |
Splits
1 split · OTC:NVSEF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 96-for-91 | Split |
- Ticker
- OTC:NVSEF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Latest earnings call · Oct 27, 2026
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 91 slides
Calls
Replays
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Tue, Oct 27, 2026 · 7:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q2 2026 Earnings Call
Tue, Jul 21, 2026 · 8:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Oct 27, 2026
Closed $150.12 (0.0%) on Oct 27, 2026
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Oct 23, 2026
Closed $149.81 (+2.5%) on Oct 23, 2026
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
Oct 21, 2026
Closed $146.18 (-0.2%) on Oct 21, 2026
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Oct 7, 2026
Closed $135.75 (+1.1%) on Oct 8, 2026
CAS ประกาศความร่วมมือกับ Novartis เพื่อขับเคลื่อนระบบข้อมูลด้านปฏิกิริยาเคมีที่พร้อมรองรับ AI
Sep 29, 2026
Closed $144.94 (-0.7%) on Sep 29, 2026
Issued by another party
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Sep 18, 2026
Closed $133.70 (-5.9%) on Sep 18, 2026
Sironax Announces Option Exercise and Asset Purchase
Sep 16, 2026
Closed $133.70 (-5.9%) on Sep 18, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 91 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 46 slides · Oct 23, 2026
Q2 2026 Earnings Presentation
Earnings · 87 slides · Jul 21, 2026
Q1 2026 Earnings Presentation
Earnings · 85 slides · Apr 28, 2026
Novartis AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 84 in the last 12 months · 117 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 26 calls with a replay · 26 with a transcript · latest Oct 27, 2026
- Decks
- 186 decks · latest Oct 27, 2026
Where Novartis AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:NOVN · Home listing | SIX Swiss | Switzerland | CHF |
| NYSE:NVS | NYSE | United States | USD |
| Xetra:NOT | Xetra | Germany | EUR |
| gettex:NOT | gettex | Germany | EUR |
| OTC:NVSEF · This page | OTC | United States | USD |
| Tradegate:NOT | Tradegate | Germany | EUR |
| Milan:1NOVN | Milan | Italy | EUR |
| BCBA:NVS | BCBA | Argentina | ARS |
| LSIN:0QLR | LSIN | United Kingdom | CHF |
| gettex:NOTA | gettex | Germany | EUR |
| LS Exchange:904278 | LS Exchange | Germany | EUR |
| SIX Swiss:NOVNEE | SIX Swiss | Switzerland | CHF |
| BX Swiss:NOT | BX Swiss | Switzerland | CHF |
| Frankfurt:NOT | Frankfurt | Germany | EUR |
| Frankfurt:NOTA | Frankfurt | Germany | EUR |
| VIE:NOVN | Vienna | Austria | EUR |
| B3:N1VS34 | B3 | Brazil | BRL |
| Tradegate:NOTA | Tradegate | Germany | EUR |
| TSX:NVS | TSX | Canada | CAD |
| Lang & Schwarz:904278 | Lang & Schwarz | Germany | EUR |
| Aquis:NOVNZ | Aquis | United Kingdom | CHF |
| Cboe Canada:NOVN | Cboe Canada | Canada | CAD |
| LSE:0K9E | LSE | United Kingdom | USD |
| Cboe Canada:NVS | Cboe Canada | Canada | CAD |
| Stuttgart:NOT | Stuttgart | Germany | EUR |
| BCBA:NVSD | BCBA | Argentina | USD |
| Munich:NOT | Munich | Germany | EUR |
| LS Exchange:907122 | LS Exchange | Germany | EUR |
| BMV:NVSN | BMV | Mexico | MXN |
| BCBA:NVSC | BCBA | Argentina | USD |
| BMV:NOVNN | BMV | Mexico | MXN |
| Hamburg:NOT | Hamburg | Germany | EUR |
| BOATS:NVS | BOATS | United States | USD |
| Dusseldorf:NOT | Dusseldorf | Germany | EUR |
| BCBA:NVSB | BCBA | Argentina | ARS |
| Stuttgart:NOTA | Stuttgart | Germany | EUR |
| Dusseldorf:NOTA | Dusseldorf | Germany | EUR |
| Hanover:NOT | Hanover | Germany | EUR |
| Frankfurt:NOT1 | Frankfurt | Germany | EUR |
| Turquoise:NOVNZ | Turquoise | United Kingdom | CHF |
| BIVA:NOVNN | BIVA | Mexico | MXN |
| Lang & Schwarz:907122 | Lang & Schwarz | Germany | EUR |
| Munich:NOTA | Munich | Germany | EUR |
| Frankfurt:NOT0 | Frankfurt | Germany | EUR |
| Hamburg:NOTA | Hamburg | Germany | EUR |
| BCBA:NVS.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Novartis AG.